Stock Markets June 18, 2026 02:12 PM

Options Activity in Moderna Soars to 121,257 Contracts by Early Afternoon

Call contracts dominate flow as multiple June 18, 2026 expirations and a high-volume June 26 put draw outsized attention

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
MRNA

Options on Moderna Inc. (MRNA) traded at a volume of 121,257 contracts by 2:10 p.m. New York time today, with call activity substantially outpacing puts. The single most active contract was the June 18, 2026 $65 call. Several multi-leg call spreads tied to the June 18, 2026 expirations also registered large volumes.

Options Activity in Moderna Soars to 121,257 Contracts by Early Afternoon
MRNA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Total options volume in Moderna reached 121,257 contracts at 2:10 p.m. New York time, with calls at 92,046 and puts at 29,211.
  • The June 18, 2026 $65 call was the single most active contract with 18,162 contracts traded and 7,856 contracts of open interest.
  • Large multi-leg call spreads tied to June 18, 2026 expirations accounted for significant portions of the session's volume, including spreads totaling 12,090, 10,000 and 6,722 contracts.

Exchange data compiled by Bloomberg show Moderna Inc. options trading reached 121,257 contracts at 2:10 p.m. New York time today. Call contracts accounted for 92,046 of that total, while put contracts represented 29,211.


Most active single contract

The most-active individual option was the June 18, 2026 $65 call, which registered 18,162 contracts traded and had 7,856 contracts of open interest.


Notable put activity

The highest-volume put noted in the session was the June 26, 2026 $55 put, with 12,470 contracts traded and an open interest of 133 contracts.


Large spread transactions

Several sizeable multi-leg call spreads dominated the balance of activity, all tied to the June 18, 2026 expiration:

  • A spread pairing the June 18, 2026 $57 call with the June 18, 2026 $53 call totaled 12,090 contracts. The $53 call component recorded 6,045 contracts with 6,447 contracts of open interest, and the $57 call component also had 6,045 contracts with 6,232 contracts of open interest.
  • A spread combining the June 18, 2026 $51 call and the June 18, 2026 $48 call reached 10,000 contracts. Each leg showed 5,000 contracts; the $48 call leg had 5,586 contracts of open interest and the $51 call leg had 5,162 contracts of open interest.
  • A third spread between the June 18, 2026 $52 call and the June 18, 2026 $48.50 call totaled 6,722 contracts. The $48.50 call portion included 3,361 contracts with 3,998 contracts of open interest, while the $52 call portion consisted of 3,361 contracts with 6,465 contracts of open interest.

Market snapshot

The raw volumes show a marked skew toward call activity in the session, with calls making up the majority of options flow. Multiple large trades concentrated in the same mid-June expiration window underpinned much of the session's activity.

Where the session's flows will lead or how positions will be carried into expiry is not indicated by the volume figures alone; the data reported here are limited to trade and open interest counts for the contracts cited.

Risks

  • Large volume relative to open interest in specific strikes creates uncertainty about whether trades represent new positions or closing activity - for example, the June 26, 2026 $55 put showed 12,470 contracts traded but only 133 contracts of open interest.
  • Concentration of volume in a narrow expiration window (multiple June 18, 2026 contracts and spreads) introduces time-sensitivity for those positions as the expiration approaches.
  • A pronounced imbalance toward call volume (92,046 calls versus 29,211 puts) indicates one-sided activity in the options market, creating uncertainty about market intentions behind the trades.

More from Stock Markets

Moody's Affirms Arbor Realty Ratings, Lowers Outlook to Negative Jun 18, 2026 Penske Media Completes Purchase of Vox Media, Forms PMX to Oversee Expanded Portfolio Jun 18, 2026 U.S.-Iran Interim Accord Sends Major Defense Stocks Lower Jun 18, 2026 Guggenheim Picks Abivax as Top Biotech Idea Ahead of ABTECT Part Two Readout Jun 18, 2026 Two Approaches to Iran: How Trump’s Memorandum Stacks Up Against Obama’s JCPOA Jun 18, 2026